# A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

> **NCT03951805** · PHASE2 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 205 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Insulin icodec
- **DRUG:** Insulin Glargine

## Key facts

- **NCT ID:** NCT03951805
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-09
- **Primary completion:** 2019-12-12
- **Final completion:** 2020-01-17
- **Target enrollment:** 205 (ACTUAL)
- **Last updated:** 2021-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03951805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03951805, "A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03951805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*